Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2014 11/20/2014 11/21/2014 11/24/2014 11/25/2014 Date
2.66(c) 2.6(c) 2.59(c) 2.55(c) 2.58(c) Last
87 524 111 945 86 749 142 077 131 510 Volume
0.00% -2.26% -0.38% -1.54% +1.18% Change
More quotes
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
Surperformance© rating of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 0,38 M
EBIT 2015 -30,2 M
Net income 2015 -36,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 10,3 M
EBIT 2016 -29,7 M
Net income 2016 -33,1 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 474x
Capi. / Sales 2016 17,4x
Capitalization 179 M
More Financials
Latest news on PLURISTEM THERAPEUTICS INC
5d ago PLURISTEM THERAPEUTICS : posts 1Q loss
11/12 PLURISTEM THERAPEUTICS : Granted Patents in Australia and New Zealand for Use of..
11/10 PLURISTEM THERAPEUTICS : CEO Zami Aberman to Present at Two Regenerative Medicin..
11/06 PLURISTEM THERAPEUTICS : Management's Discussion and Analysis of Financial Condi..
11/05 PLURISTEM THERAPEUTICS INC. : Pluristem Therapeutics Developing Off-The-Shelf Ce..
10/29 PLURISTEM THERAPEUTICS : Case Western Reserve University to Study Pluristem's PL..
10/21 PLURISTEM THERAPEUTICS : Advances Its Second Major Cell Therapy Product Line Fro..
10/17 PLURISTEM THERAPEUTICS INC. : Pluristem's Therapy for Muscle and Tendon Regenera..
10/17 PLURISTEM THERAPEUTICS : Therapy for Muscle and Tendon Regeneration May Revoluti..
10/07 PLURISTEM THERAPEUTICS : Wins Cell Therapy Patent Case in Europe; European Paten..
10/01 PLURISTEM THERAPEUTICS : Coverage Initiation Report Focuses on Pluristem Therape..
09/11 PLURISTEM THERAPEUTICS : Termination of a Material Definitive Agreement (form 8-..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF